Weekly Digest: Key Advances in Weight Management, Healthy Living, and Healthy Eating

1. WHO Issues First-Ever Guidelines on GLP-1 Therapies for Obesity
On December 1, 2025, the World Health Organization released its inaugural guideline endorsing the long-term use of GLP-1 receptor agonist medications such as semaglutide, liraglutide, and tirzepatide for adults living with obesity. Currently, over 1 billion people globally have obesity, with projections reaching 2 billion by 2030. The WHO highlights that GLP-1 medications are most effective when combined with structured lifestyle programs that emphasize healthy eating, regular physical activity, and continued behavioral counseling. This landmark guidance recognizes obesity as a chronic disease requiring comprehensive management beyond medication alone.

2. Liraglutide Slows Alzheimer's Disease Progression and Brain Shrinkage
A December 2025 study published by Imperial College London and Nature Medicine demonstrated that the GLP-1 drug liraglutide, primarily used for diabetes and weight loss, reduced brain shrinkage in Alzheimer's patients by nearly 50%. In a phase 2b trial of 204 patients over one year, liraglutide achieved an 18% slower cognitive decline compared to placebo. This evidence provides promising support that GLP-1 therapies may have neuroprotective effects, possibly linked to improved brain metabolism and inflammation reduction.

3. Vigorous Exercise Far Outperforms Walking for Heart Health and Diabetes Prevention
New research from the University of Sydney shows vigorous-intensity physical activity is six times more effective at lowering cardiovascular disease risk than moderate-intensity activities like walking. Specifically, one minute of vigorous exercise equals 9.4 minutes of moderate activity in diabetes prevention effectiveness and 7.8 minutes for cardiovascular mortality risk reduction. These findings emphasize the efficiency of short bouts of intense exercise for improving metabolic health.

4. Policy Shift: Medi-Cal to Stop Coverage of GLP-1 Drugs for Weight Loss
Effective January 1, 2026, California's Medi-Cal program will cease coverage of GLP-1 medications prescribed solely for weight loss in adults over 21. Alternate FDA-approved indications such as treatment of type 2 diabetes will remain covered. This policy change may impact access to effective pharmacological weight management options and underscore the importance of holistic lifestyle interventions.

5. Minimally Processed Diet Doubles Weight Loss Versus Ultra-Processed Diet
A controlled feeding study found that participants consuming a minimally processed diet lost nearly twice as much weight (2% of body weight) compared with those on an ultra-processed diet (1% loss) despite consuming equal calories. Additionally, those on the minimally processed diet reported fewer digestive issues including constipation and reflux, as well as improved sleep and energy levels. This highlights the metabolic and health benefits intrinsic to less processed foods.

Collectively, these advances reinforce evidence-based approaches to weight management and metabolic health that integrate pharmacologic innovation, physical activity intensity, dietary food quality, and public health policy. Emerging therapies like GLP-1 receptor agonists show promise but must be embedded in comprehensive lifestyle frameworks for sustainable benefits. Additionally, the power of vigorous exercise and minimally processed nutrition deserve greater emphasis in public guidance and clinical practice.

Sources

• https://www.who.int/news-room/events/detail/2025/12/01/default-calendar/from-evidence-to-action--who-guideline-on-the-use-of-glucagon-like-peptide-1-(glp-1)-therapies-for-the-treatment-of-obesity-in-adults
• https://www.imperial.ac.uk/news/articles/2025/-weight-loss-drug-liraglutide-slowed-alzheimers-decline/
• https://www.independent.co.uk/health-and-fitness/exercise-more-effective-walking-heart-health-b2878666.html
• https://medi-calrx.dhcs.ca.gov/cms/medicalrx/static-assets/documents/member/GLP1_Changes.pdf
• https://www.prevention.com/food-nutrition/healthy-eating/a65664887/ultra-processed-foods-weight-loss-gut-health-study/